UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000008571 |
|---|---|
| Receipt number | R000009793 |
| Scientific Title | Phase II study of weekly fractionated hepatic arterial infusion of Sorafenib and Cisplatin for advanced hepatocellular carcinoma. |
| Date of disclosure of the study information | 2012/07/31 |
| Last modified on | 2021/02/04 19:00:22 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/07/30 17:20:19 | ||
| 2 | Update | 2014/01/21 18:12:40 | Email |
|
| 3 | Update | 2014/01/30 15:43:44 | Recruitment status |
|
| 4 | Update | 2014/03/08 16:38:29 | Recruitment status |
|
| 5 | Update | 2016/08/03 10:18:49 | Recruitment status |
|
| 6 | Update | 2017/08/03 19:50:10 | Name of primary person or sponsor Organization |
|
| 7 | Update | 2017/08/03 19:51:03 | Recruitment status |
|
| 8 | Update | 2021/02/04 19:00:22 | Recruitment status Date of IRB Last follow-up date |
